Atenolol
SIGMA/A7655 - ≥98% (TLC), powder
Synonym: (±)
CAS Number: 29122-68-7
Empirical Formula (Hill Notation): C14H22N2O3
Molecular Weight: 266.34
EC Number: 249-451-7
MDL Number: MFCD00057645
Linear Formula: C14H22N2O3
Product Type: Chemical
assay | ≥98% (TLC) |
color | white to off-white |
form | powder |
InChI | 1S/C14H22N2O3/c1-10(2)16- |
InChI key | METKIMKYRPQLGS-UHFFFAOYSA |
originator | AstraZeneca |
Quality Level | 200 |
SMILES string | CC(C)NCC(O)COc1ccc(CC(N)= |
solubility | DMSO: 18 mg/mL |
ethanol: 3.4 mg/mL | |
H2O: 0.3 mg/mL |
Application: | Atenolol is a β-adrenergic blocker and used in the management of hypertension. Atenolol has antianginal and antiarrhythmic properties. |
Biochem/physiol Actions: | Selective β1-adrenoceptor antagonist; antihypertensive; antianginal; antiarrhythmic. |
Features and Benefits: | This compound is featured on the β-Adrenoceptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
Features and Benefits: | This compound was developed by AstraZeneca . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
Other Notes: | Shelf-life of the solid is at least three years. |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 2 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (TLC) |
UNSPSC | 12352200 |